PolyNovo Limited (ASX:PNV)

Market Cap	825.56M
Revenue (ttm)	128.70M
Net Income (ttm)	13.21M
Shares Out	690.84M
EPS (ttm)	0.02
PE Ratio	63.23
Forward PE	52.07
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,436,414
Average Volume	2,284,075
Open	1.240
Previous Close	1.240
Day's Range	1.190 - 1.245
52-Week Range	0.930 - 2.360
Beta	1.69
RSI	38.91
Earnings Date	Nov 24, 2025

About PolyNovo

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; Beta Cell implant, a novel intracutaneous ectopic pancreas to tre...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 301
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: PNV

Financial Performance

In 2025, PolyNovo's revenue was 128.70 million, an increase of 24.67% compared to the previous year's 103.23 million. Earnings were 13.21 million, an increase of 151.17%.